世卫组织总干事谭德塞表示，目前正与另外四家生产商进行讨论，并对另外九种疫苗进行长期评估。

"The facility is the critical mechanism for joint procurement and pooling risk across multiple vaccines so that whichever vaccine is proven to be safe and effective, all countries within the facility will be able to access them," he said during a virtual news briefing from Geneva.

他在日内瓦举行的一场在线资讯发布会上说：“这是联合采购多种疫苗并分担风险的关键机制，以便无论哪种疫苗被证明是安全和有效的，该机制内的所有国家都能获得这些疫苗。”

pool [puːl]：vt.合伙经营

A woman holds a small bottle labeled with a "Vaccine COVID-19" sticker and a medical syringe in this illustration taken on April 10, 2020. [Photo/Agencies]

He emphasized that the most important thing is that the mechanism enables a globally coordinated rollout.

他强调说，最重要的是，该机制使全球合作推出疫苗成为可能。

The WHO is working with vaccine manufacturers to provide all countries that join the effort with timely and equitable access to all approved vaccines.

世卫组织正与疫苗生产商合作，为所有参与这一计划的国家及时和公平地提供所有经批准的疫苗。

"This doesn't just pool risk, it also means that prices will be kept as low as possible," Tedros said.

【世卫组织：希望2021年年底前提供20亿剂新冠疫苗】相关文章：

★ 北京奥运主题歌《我和你》传递温暖

★ 印尼体育部长受腐败调查影响辞职

★ 全球氦气供应短缺

★ 中日领土争端令日本旅游业损失惨重

★ 分析：中美角力东南亚

★ 民众提前45小时排队买奥运门票

★ l played with some kangaroos

★ 英国高校校长反对移民限制

★ 韩国：朝鲜可能试射弹道导弹

★ 香港担心美国QE3的影响